N-(Benzyloxy)-5-methyl-2-phenyloxazole-4-carboxamide, 98%, 2.5g

1-[1-(4-methoxyphenyl)-1H-pyrazol-4-yl]ethanone, 95.0%, 5g

1,2-Bis(4-methoxyphenyl)-2-oxoethyl cyclohexylcarbamate, 98%, 5g

Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97.0%, 1g

tert-Butyl 4-(4-Bromo-1H-pyrazol-1-yl)piperidine-1-carboxylate, 97.0%, 1g

(S)-N-(Pyrrolidin-3-yl)acetamide hydrochloride, 95.0%, 500mg

2,7-Di-tert-butylpyrene>98.0%(GC)5g

4-Methoxy-2-vinylpyridine, 95.0%, 1g

Pipette capillari con eparinazione di sodio, 60 µl, 1000 pezzi

(S)-5-bromo-2,3-dihydrobenzofuran-3-amine, 98%, 100mg

3-Hydrazinyl-4-methylpyridazine, 90%, 1g

1,3-Dibromo-2-propanol (stabilized with Copper chip)>95.0%(GC)100mL

Cartello informativo SEKUROKA®, Test di funzionamento notturno, 100 x 300 mm, Plastica da appendere, 1 pezzo